Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center study
Familial Cancer · 2021-10 · 20 (4) · 263-271
DOI: 10.1007/s10689-021-00237-1 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Familial Cancer, online erschienen am 09.03.2021. Verfasst von Floor A M Postema und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting Kinderen Kankervrij.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Recognizing a tumor predisposition syndrome (TPS) in a child with cancer is of clinical relevance. Earlier we developed a screening tool to increase diagnostic accuracy and clinical efficiency of identifying TPSs in children with cancer. Here we report on the value of this tool in clinical practice. TuPS is a prospective, observational, multi-center study including children newly diagnosed with cancer from 2016 to 2019 in the Netherlands. Children in whom a TPS had been diagnosed before the cancer diagnosis were excluded. The screening tool consists of a checklist, 2D and 3D photographic series and digital assessment of these by a clinical geneticist. If a TPS was suspected, the patient was assessed positive and referred for routine genetic consultation. Primary aim was to assess the clinical value of this new screening tool. Of the 363 included patients, 57% (208/363) were assessed positive. In 15% of patients (32/208), the 2D photographic series with (n = 12) or without (n = 20) 3D photographs were decisive in the positive assessment. In 2% (4/208) of positive assessed patients, a TPS was diagnosed, and in an additional 2% (4/208) a germline variant of uncertain significance was found. Thirty-five negatively assessed patients were evaluated through routine genetic consultation as controls, in none a TPS was detected. Using the screening tool, 57% of the patients were assessed as suspected for having a TPS. No false negative results were identified in the negative control group in the clinical care setting. The observed prevalence of TPS was lower than expected, due to selection bias in the cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
- Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
- Clinical Research Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Department of Clinical Genetics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
ORCID-Profile: Floor A M Postema
Förderung
- Stichting Kinderen Kankervrij
Zitieren
APA
Postema, F. A. M., Hopman, S. M. J., de Borgie, C. A. J. M., Aalfs, C. M., Anninga, J. K., Berger, L. P. V., Bleeker, F. E., Dommering, C. J., van Eijkelenburg, N. K. A., Hammond, P., van den Heuvel-Eibrink, M. M., Hol, J. A., Kors, W. A., Letteboer, T. G. W., Loeffen, J. L. C. M., Meijer, L., Olderode-Berends, M. J. W., Wagner, A., Hennekam, R. C., & Merks, J. H. M. (2021). Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center study. Familial Cancer, 20(4), 263-271. https://doi.org/10.1007/s10689-021-00237-1
Vancouver
Postema FAM, Hopman SMJ, de Borgie CAJM, Aalfs CM, Anninga JK, Berger LPV, et al. Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center study. Familial Cancer. 2021;20(4):263-271. doi:10.1007/s10689-021-00237-1
BibTeX
@article{Postema2021,
author = {Postema, Floor A M and Hopman, Saskia M J and de Borgie, Corianne A J M and Aalfs, Cora M and Anninga, Jakob K and Berger, Lieke P V and Bleeker, Fonnet E and Dommering, Charlotte J and van Eijkelenburg, Natasha K A and Hammond, Peter and van den Heuvel-Eibrink, Marry M and Hol, Janna A and Kors, Wijnanda A and Letteboer, Tom G W and Loeffen, Jan L C M and Meijer, Lisethe and Olderode-Berends, Maran J W and Wagner, Anja and Hennekam, Raoul C and Merks, Johannes H M},
title = {Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center study},
journal = {Familial Cancer},
year = {2021},
volume = {20},
number = {4},
pages = {263--271},
doi = {10.1007/s10689-021-00237-1}
}
EUVIMED